美托洛尔联合稳心颗粒治疗老年缺血性 心律失常的治疗效果分析.docVIP

美托洛尔联合稳心颗粒治疗老年缺血性 心律失常的治疗效果分析 　　摘要:目的:探究美托洛尔联合稳心颗粒治疗老年缺血性心律失常的临床治疗效果。方法:选取我院2011年4月~2013年4月门诊及住院部64例老年缺血性心律失常患者作为研究对象，按照治疗方法的不同分为实验组和对照组，对照组患者予以美托洛尔治疗，实验组患者在对照组的基础上加用稳心颗粒治疗，观察记录两组患者临床治疗效果及用药后不良反应情况。结果:两组患者经治疗后，临床疗效总有效率比较，实验组明显高于对照组，p0.05，差异具有统计学意义；两组患者用药后总不良反应率比较，实验组明显比对照组低，p0.05，差异具有统计学意义。结论:采取美托洛尔联合稳心颗粒治疗老年缺血性心律失常具有显著的临床治疗效果，可改善患者心律失常情况，且不良反应少、安全性高，是临床上治疗老年缺血性心律失常的首选方法。 　　关键词:美托洛尔；稳心颗粒；老年缺血性心律失常 　　 abstract : objective to explore the metoprolol combined metacentre grain clinical treatment effect for the treatment of senile ischemic arrhythmias. Methods select our hospital in April 2011 ~ April 2013 outpatient and the inpatient 64 patients with senile ischemic arrhythmias as the research object, according to different divided into experimental group and the control group, treatment group patients give metoprolol treatment, the experimental group patients in the control group treated with metacentric particles, on the basis of observation records in the two groups patients clinical therapeutic effect and drug adverse reactions after the situation. Results two groups of patients after treatment, the clinical curative effect of total effective rate comparison, the experimental group is significantly higher than the control group, p 0.05, the difference is statistically significant; Two groups of patients after total adverse reaction rate comparison, the experimental group was obviously lower than the control group, p 0.05, the difference is statistically significant. Conclusion taking metoprolol combined metacentric particles of senile ischemic arrhythmias has significant clinical effect, can improve patients with arrhythmia, and less adverse reaction, high safety, is clinically preferred method for the treatment of senile ischemic arrhythmias. 　　key words : metoprolol; Metacentric particles; Senile ischemic arrhythmias 　　近年来，随着人们的生活条件不断改善，冠心病的发病率逐渐上升，成为心血管内科最为常见的一种疾病[1]。冠心病患病人群中男性高于女性，随着年龄的增长，发病率也在提高，严重威胁着老年人的身体健康及生命安全。心律失常是指由于心脏活动传导或者起源受阻而导致的心脏搏动节律和频率失常，多